Literature DB >> 11544565

Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas.

M Katai1, A Sakurai, Y Ikeo, K Hashizume.   

Abstract

A prospective study on the natural course of primary hyperparathyroidism has recently been reported. Since hyperparathyroidism in multiple endocrine neoplasia type 1 (MEN 1) is genetically distinct from most forms of sporadic hyperparathyroidism, it is important to know the natural course of hyperparathyroidism in MEN 1 for better clinical management. For this purpose, we retrospectively reviewed clinical parameters of patients with MEN 1 when they were diagnosed as having hyperparathyroidism, and compared them with those of patients with sporadic primary hyperparathyroidism. In patients with MEN 1: 1) levels of intact PTH (i-PTH) gradually increased with age, which accelerated over 40 years; 2) compared to the steep rise in i-PTH levels in aged patients, increase in serum calcium or decrease of serum inorganic phosphate concentration was relatively mild, and 3) the high concentrations of i-PTH in aged patients were not due to renal insufficiency. These features were not observed in patients with sporadic primary parathyroid adenomas. Clinical features of untreated hyperparathyroidism in MEN 1 may be significantly affected by the age of the patient. The effect, if any, of age-dependent deterioration on recurrence rate after subtotal or total parathyroidectomy requires further elucidation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11544565     DOI: 10.1055/s-2001-16944

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Preoperative localizing studies for initial parathyroidectomy in MEN1 syndrome: is there any benefit?

Authors:  Naris Nilubol; Lee Weinstein; William F Simonds; Robert T Jensen; Giao Q Phan; Marybeth S Hughes; Steven K Libutti; Stephen Marx; Electron Kebebew
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.

Authors:  Jeffrey A Norton; David J Venzon; Marc J Berna; H R Alexander; Douglas L Fraker; Stephen K Libutti; Stephen J Marx; Fathia Gibril; Robert T Jensen
Journal:  Ann Surg       Date:  2008-03       Impact factor: 12.969

3.  Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up.

Authors:  Bas A Twigt; Anouk Scholten; Gerlof D Valk; Inne H M Borel Rinkes; Menno R Vriens
Journal:  Orphanet J Rare Dis       Date:  2013-04-01       Impact factor: 4.123

Review 4.  Post-surgical follow-up of primary hyperparathyroidism associated with multiple endocrine neoplasia type 1.

Authors:  Flavia L Coutinho; Delmar M Lourenco; Rodrigo A Toledo; Fabio L M Montenegro; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

Review 5.  Biochemical, bone and renal patterns in hyperparathyroidism associated with multiple endocrine neoplasia type 1.

Authors:  Delmar M Lourenço; Flavia L Coutinho; Rodrigo A Toledo; Tatiana Denck Gonçalves; Fabio L M Montenegro; Sergio P A Toledo
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

6.  Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors.

Authors:  Sena Hwang; Jong Ju Jeong; Se Hoon Kim; Yoon Jung Chung; Sun Yong Song; Yang Jong Lee; Yumie Rhee
Journal:  Sci Rep       Date:  2018-08-13       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.